BioNTech
NEWS
News, much of it good, keeps coming in about the efficacy of the various COVID-19 vaccines. Here’s a look.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Yesterday it was reported that the two companies were working to make more of their vaccine than the 1.3 billion it promised to manufacture in 2021.
In a December 8, 2020 meeting with U.K. scientists and public health experts, it was announced that there was a growing new strain of the SARS-CoV-2 virus that causes COVID-19.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 22, 2020.
Many companies appear to be getting their clinical trial news updated ahead of the holidays. Here’s a look.
As Pfizer-BioNTech and the U.S. government begin the historic rollout of COVID-19 vaccine distribution around the U.S. and the world, there have been a few glitches. This isn’t unexpected.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 15, 2020.
If the U.S. Food and Drug Administration does not grant Emergency Use Authorization to the COVID-19 vaccine developed by Pfizer and BioNTech, the White House will demand the resignation of FDA Commissioner Stephen Hahn.
JOBS
IN THE PRESS